CD8A and neoplasm: In mouse tumor models of ovarian, colon cancer, and melanoma, CAR-T cells can selectively clear M2 macrophages in the TME by targeting FRβ receptors, leading to the accumulation of pro-inflammatory monocytes and increase of CD8+T cell numbers in the TME.